✦ LIBER ✦

Antiangiogenic and antitumor effect of VEGF antisense oligonucleotide in combination with anti-EGFR C225 monoclonal antibody in human colon cancer

✍ Scribed by F. Ciardiello; R. Bianco; V. Damiano; R. Caputo; S. De Placido; G. Fontanini; S. Agrawal; J. Mendelsohn; A.R. Bianco; G. Tortora

Book ID: 117667338
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 119 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)80791-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Human Monoclonal Anti-ANG2 Antibody Le

A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

✍ Brown, J. L.; Cao, Z. A.; Pinzon-Ortiz, M.; Kendrew, J.; Reimer, C.; Wen, S.; Zh 📂 Article 📅 2010 🏛 American Association for Cancer Research 🌐 English ⚖ 815 KB

Enhanced antitumor activity of anti-epid

Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody cetuximab (IMC-C225) in combination with irinotecan (CPT-11), 5-FU, and leucovorin against human colorectal carcinoma xenografts

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 157 KB

378 In vivo and in vitro enhanced antitu

378 In vivo and in vitro enhanced antitumor activity of Oxaliplatin in combination with cetuximab (C225), a chimeric monoclonal antibody anti-epidermal growth factor receptor on a panel of human colorectal tumor xenografts

✍ D. Balin; J.P. Delord; P. Rochaix; V. Mallard; F. Thomas; I. Hennebelle; R. Buga 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 279 KB